This episode delves into the emerging therapeutic landscape for chronic subdural hematoma (cSDH), focusing on the combined approach of middle meningeal artery embolization and subdural evacuation port system (MMAE-SEPS) drainage. Drawing from a systematic review, single-arm meta-analysis, meta-regression, and cost-benefit analysis published in Clinical Neurology and Neurosurgery in 2026, this abstract review examines the safety, efficacy, and economic implications of this minimally invasive strategy. The discussion highlights findings in a population of older, medically frail patients at risk for recurrence and perioperative complications. The clinical implications for reducing cSDH recurrence and improving patient outcomes are explored. Please note: This podcast content is for informational purposes only and does not constitute medical advice.